Pharmaceutical companies are constantly aiming for shorter drug-development cycles and advances in formulation development produce significant benefits. There is an increasing need for efficient ...

AI, ML, and statistical algorithms guide solubilization method selection, demonstrated with compound CVN424. In a poster presentation at AAPS PharmSci 360, by Dineli Ranathunga, PhD, indicates that AI ...

Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The "Pharma Formulation Development Outsourcing Market Size and Growth Trends and Companies 2025-2033" report has been added to ResearchAndMarkets.com's ...

LEXINGTON, KY--(Marketwired - Nov 18, 2013) - Coldstream Laboratories, Inc., a provider of sterile drug product development and manufacturing services, has announced that Adrian Raiche, Ph.D. has ...

Iconovo, which develops inhalable drugs based on proprietary inhalers and dry powder formulations, reports that it and Lonza initiated a collaboration to develop spray-dried formulations of an ...

SACRAMENTO, Calif., May 19, 2025 /PRNewswire/ -- Persist AI, a pioneer in AI-driven robotics for pharmaceutical formulation development and Chemistry, Manufacturing, and Controls (CMC), today ...

Coriolis’ new ATMP facilities will meet the growing demand for formulation development and analytical characterization for ATMPs up to BSL2/S2 level and increase Coriolis’ capabilities significantly.

The aim of any formulation scientist is to create a product that is safe, effective, stable, and distinct from competitor drugs. It also helps if the product is as patient friendly as possible to ...

The global formulation development outsourcing market is on a significant growth trajectory, with a projected compound annual growth rate (CAGR) of 7.2% over the next decade. Valued at USD 33.23 ...

This unique 3 day course is designed to integrate the key elements of tablet development with hands-on, practical experience in a small scale, lab scale test facility. Each day will consist of ...

There has been recent progress on the development of pediatric drug formulations, but further development of better medicines for children should focus on a certain set of priorities, according to a ...